Quick Answer
Core Scientific, Inc./tx reported Diluted EPS of $0.88 per share (loss) for fiscal year 2025.
Core Scientific, Inc./tx Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.88 | +81.9% |
| 2024 | -$4.87 | -649.2% |
| 2023 | -$0.65 | +89.7% |
| 2022 | -$6.30 | -3250.0% |
| 2021 | $0.20 | +242.9% |
| 2020 | -$0.14 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.46 | +60.7% | -1050.0% |
| June 30, 2025 | -$0.04 | +99.1% | -103.2% |
| March 31, 2025 | $1.25 | +60.3% | +206.8% |
| September 30, 2024 | -$1.17 | -963.6% | +74.1% |
| June 30, 2024 | -$4.51 | -22450.0% | -678.2% |
| March 31, 2024 | $0.78 | — | +809.1% |
| September 30, 2023 | -$0.11 | +91.1% | -450.0% |
| June 30, 2023 | -$0.02 | +99.2% | — |
- Core Scientific, Inc./tx showed an increase of +81.9% in Diluted EPS compared to the prior fiscal year.
- Over the 2020–2025 period, Core Scientific, Inc./tx’s diluted eps has declined by 528.6% (from $0.14 per share (loss) to $0.88 per share (loss)).
- The most recent figure is from Core Scientific, Inc./tx’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 2, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: